Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022-2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants.

Horváth, Judit Krisztina; Túri, Gergo; Krisztalovics, Katalin; Kristóf, Katalin; Oroszi, Beatrix

Horváth, Judit Krisztina; Túri, Gergo; Krisztalovics, Katalin; Kristóf, Katalin; Oroszi, Beatrix.

Afiliação

Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, 1085 Budapest, Hungary.
Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, 1085 Budapest, Hungary.
Krisztalovics K; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, 1085 Budapest, Hungary.
Kristóf K; Institute of Laboratory Medicine, Clinical Microbiology Laboratory, Semmelweis University, 1085 Budapest, Hungary.
Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, 1085 Budapest, Hungary.

Vaccines (Basel) ; 12(5)2024 May 04.

Article em En | MEDLINE | ID: mdl-38793747

Palavras-chave

COVID-19; Omicron subvariants; SARS-CoV-2; booster vaccination; hybrid immunity; primary care; reinfection; test-negative design; vaccine effectiveness

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Hungria País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google